Attitudes of Genetics Professionals Toward the Return of Incidental Results from Exome and Whole-Genome Sequencing

被引:87
|
作者
Yu, Joon-Ho [1 ]
Harrell, Tanya M. [1 ]
Jamal, Seema M. [1 ]
Tabor, Holly K. [1 ,2 ]
Bamshad, Michael J. [1 ,3 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[2] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA
[3] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
关键词
ACMG RECOMMENDATIONS; CLINICAL GENOMICS; PERSPECTIVES; VARIANTS; GENES;
D O I
10.1016/j.ajhg.2014.06.004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Professional recommendations for the return of results from exome and whole-genome sequencing (ES/WGS) have been controversial. The lack of clear guidance about whether and, if so, how to return ES/WGS incidental results limits the extent to which individuals and families might benefit from ES/WGS. The perspectives of genetics professionals, particularly those at the forefront of using ES/WGS in clinics, are largely unknown. Data on stakeholder perspectives could help clarify how to weigh expert positions and recommendations. We conducted an online survey of 9,857 genetics professionals to learn their attitudes on the return of incidental results from ES/WGS and the recent American College of Medical Genetic and Genomics Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Of the 847 respondents, 760 completed the survey. The overwhelming majority of respondents thought that incidental ES/WGS results should be offered to adult patients (85%), healthy adults (75%), and the parents of a child with a medical condition (74%). The majority thought that incidental results about adult-onset conditions (62%) and carrier status (62%) should be offered to the parents of a child with a medical condition. About half thought that offered results should not be limited to those deemed clinically actionable. The vast majority (81%) thought that individual preferences should guide return. Genetics professionals' perspectives on the return of ES/WGS results differed substantially from current recommendations, underscoring the need to establish clear purpose for recommendations on the return of incidental ES/WGS results as professional societies grapple with developing and updating recommendations.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 50 条
  • [21] Whole-genome and whole-exome sequencing in neurological diseases
    Jia-Nee Foo
    Jian-Jun Liu
    Eng-King Tan
    Nature Reviews Neurology, 2012, 8 : 508 - 517
  • [22] Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study
    Lemke, A. A.
    Bick, D.
    Dimmock, D.
    Simpson, P.
    Veith, R.
    CLINICAL GENETICS, 2013, 84 (03) : 230 - 236
  • [23] Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants
    Belkadi, Aziz
    Bolze, Alexandre
    Itan, Yuval
    Cobat, Aurelie
    Vincent, Quentin B.
    Antipenko, Alexander
    Shang, Lei
    Boisson, Bertrand
    Casanova, Jean-Laurent
    Abel, Laurent
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (17) : 5473 - 5478
  • [24] Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues
    Hallowell, Nina
    Hall, Alison
    Alberg, Corinna
    Zimmern, Ron
    JOURNAL OF MEDICAL ETHICS, 2015, 41 (04) : 317 - 321
  • [25] Exome and whole-genome sequencing for gene discovery: The future is now!
    Majewski, Jacek
    Rosenblatt, David S.
    HUMAN MUTATION, 2012, 33 (04) : 591 - 592
  • [26] Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings
    Van der Merwe, Nicole
    Ramesar, Raj
    De Vries, Jantina
    FRONTIERS IN GENETICS, 2022, 13
  • [27] Knowledge, attitudes, and beliefs of parents toward whole-genome sequencing in pediatric cancer.
    Ruiz, Jenny
    Bender, Julia Lynne Glade
    Oberg, Jennifer
    Cohn, Elizabeth
    Levine, Jennifer
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy
    Francesco Mazzarotto
    Iacopo Olivotto
    Roddy Walsh
    Cardiovascular Drugs and Therapy, 2020, 34 : 241 - 253
  • [29] Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy
    Mazzarotto, Francesco
    Olivotto, Iacopo
    Walsh, Roddy
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 241 - 253
  • [30] Readability of informed consent forms for whole-exome and whole-genome sequencing
    Niemiec E.
    Vears D.F.
    Borry P.
    Howard H.C.
    Journal of Community Genetics, 2018, 9 (2) : 143 - 151